Acquired Osteomalacia Associated with Autoantibodies against PHEX
Yoshitomo Hoshino(University of Tokyo Hospital), Nobuaki Ito(University of Tokyo Hospital), Taku Saito(The University of Tokyo), So Watanabe(University of Tokyo Hospital), Masaomi Nangaku(The University of Tokyo), Peter D. Burbelo(National Institutes of Health), Sakae Tanaka(University of Tokyo Hospital), Hajime Katô(University of Tokyo Hospital), Kazuo Okamoto(The University of Tokyo), Yuka Kinoshita(University of Tokyo Hospital), Naoko Hidaka(University of Tokyo Hospital), Noriko Makita(University of Occupational and Environmental Health Japan), Soichiro Kimura(Kinjo Gakuin University), Tomohiro Ogawa(The University of Tokyo), Daisuke Hagiwara(Nagoya University), Hiroshi Takayanagi(Tokyo Medical and Dental University), Hiroshi Kobayashi(Jikei University School of Medicine), Koki Irie(University of Tokyo Hospital), Masakazu Kogawa
Cited by 8
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.
|Journal of Clinical Investigation|1993|577
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling system
|Immunological Reviews|2005|324
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
|JCI Insight|2016|304
Excessive mechanical loading promotes osteoarthritis through the gremlin-1–NF-κB pathway
|Nature Communications|2019|289